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Abstract
Background: Just as power, type I error of cluster detection tests (CDTs) should be spatially assessed. Indeed, CDTs’
type I error and power have both a spatial component as CDTs both detect and locate clusters. In the case of type
I error, the spatial distribution of wrongly detected clusters (WDCs) can be particularly affected by edge effect. This
simulation study aims to describe the spatial distribution of WDCs and to confirm and quantify the presence of
edge effect.
Methods: A simulation of 40 000 datasets has been performed under the null hypothesis of risk homogeneity. The
simulation design used realistic parameters from survey data on birth defects, and in particular, two baseline risks.
The simulated datasets were analyzed using the Kulldorff’s spatial scan as a commonly used test whose behavior is
otherwise well known. To describe the spatial distribution of type I error, we defined the participation rate for each
spatial unit of the region. We used this indicator in a new statistical test proposed to confirm, as well as quantify,
the edge effect.
Results: The predefined type I error of 5% was respected for both baseline risks. Results showed strong edge effect
in participation rates, with a descending gradient from center to edge, and WDCs more often centrally situated.
Conclusions: In routine analysis of real data, clusters on the edge of the region should be carefully considered as
they rarely occur when there is no cluster. Further work is needed to combine results from power studies with this
work in order to optimize CDTs performance.
Keywords: Cluster detection test, Type I error, Simulation study, Edge effect, Spatial scan
Résumé
Contexte: Les tests de détection de clusters (CDT) permettent à la fois de détecter et de localiser les clusters. Au
même titre que pour la puissance, il est donc nécessaire d’étudier la répartition spatiale de l’erreur de type I de ces
CDT. Dans le cas de l’erreur de type I, la répartition spatiale des clusters détectés à tort (WDC) peut être
particulièrement concernée par un effet de bord. Cette étude de simulation a pour objectif de décrire la
distribution spatiale des WDCs et de confirmer et quantifier la présence de cet effet de bord.
(Continued on next page)
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Méthodes: Ce travail s’appuie sur la synthèse de 40 000 jeux de données simulant l’hypothèse nulle
d’homogénéité spatiale des risques. Les simulations étaient fondées sur les paramètres réels de données d’un
registre de malformations congénitales, et notamment sur deux risques de base réels. La description de la
distribution spatiale de l’erreur de type I nous a conduits à définir le concept de taux de participation de chaque
unité spatiale de la région. Cet indicateur a ensuite été intégré pour la construction d’un nouveau test statistique
destiné à confirmer et quantifier l’effet de bord.
Résultats: La valeur globale de l’erreur de type I à 5% a bien été retrouvée. Les résultats montraient un très net
effet de bord avec un gradient décroissant du taux de participation depuis le centre vers le bord, les WDC étant
plus souvent situés en zone centrale.
Conclusions: Lors de la mise en œuvre des CDT sur données réelles, les détections de clusters près du bord d’une
région d’étude doivent être examinées avec la plus grande attention, ces dernières étant très rares en l’absence de
cluster réel. Il est maintenant nécessaire d’orienter de futurs développements vers la combinaison de ces résultats à
ceux des études de puissance, et ce dans le but d’optimiser les performances des CDT.
Background
Spatial clusters can be detected using a wide range of
statistical tests [1,2] many of which are available in free
software such as R [3,4]. Epidemiologists use cluster
detection tests (CDTs) to detect clusters without a priori
knowledge either of their number or their location, and
to determine their significance. CDTs performance being
a function of epidemiological and geographical context
[1,5-11], it is recommended to perform power studies be-
fore using these tests in a particular region for a given
phenomenon. However, statistical power is not the only test
characteristic determining performance. Performance at
large depends on two type of risks: type I and type II errors.
In presence of clusters, usual statistical power (1-β) is
not sufficient to assess CDT performance to reject the
null hypothesis of risk homogeneity. At worst, a CDT
could have a maximum power to reject this null hypoth-
esis of risk homogeneity but never correctly locate the
true cluster. Similar concern can be raised for type I
error. A CDT could, under the null hypothesis of no
cluster, generate wrongly detected clusters (WDC) pref-
erentially localized in particular zones of the studied
region. The overall type I error could effectively be equal
to its predefined value usually set to 5%, but the inter-
pretation of the analyses would certainly not be the same
for detected clusters inside or outside such zones.
In the case of statistical power, authors have since used
either evaluation of power and location by different indi-
cators [6,12-14] or concomitant evaluation of both with
a single measure such as the extended power [15,16].
The development of single measure of performance
taking into account both power and location accuracy
has enabled systematic spatial evaluation of performance
on entire regions [15]. The question of the spatial evalu-
ation of CDT is, so far, not totally answered with regards
to power because evaluation of factors such as relative
risks or cluster shape and size are still assessed by a
non-systematic approach based on more or less arbitrary
settings in simulation designs.
The question of relative risks and clustering character-
istics is not relevant in the spatial evaluation of type I
error, other factors have to be taken into account, how-
ever. First, there is still one epidemiological factor that
requires setting: the baseline risk. For an applicative
purpose, the use of the baseline incidence of the studied
disease is the evident choice, but for research, a system-
atic evaluation over a wide range of this factor should be
carried out. Second, simulation studies evaluating type I
error are much more likely to be influenced by edge
effect [17-19] than power studies. Indeed, in the majority
of simulation studies assessing power, edge effect is
largely lessened by designs simulating clusters wholly
within the studied region.
We aimed to evaluate CDTs regarding the spatial dis-
tribution of type I error. Such description was carried-
out at the level of the spatial unit (SU) introducing the
concept of SU’s participation rate. We proposed a statis-
tic to quantify and test for edge effect which was of par-
ticular interest. We used Kulldorff spatial scan statistic
as an example of CDT, whose behavior is otherwise well
known, and performed a simulation study using realistic
parameters from survey data on birth defects.
Methods
Disease modeling
The study region was the Auvergne region (France),
divided into n = 221 spatial units (SUs) equivalent to U.S.
ZIP codes. We applied two baseline risks (incidences) of
birth defects to the same at-risk population, whose size
was approximated by mean annual number of live births.
For a realistic analysis, we used data archived in CEMC
(birth defects registry for the Auvergne region) and INSEE
(National Institute of Statistics and Economic Studies)
databases. We collected two categories of data from 1999
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to 2006: all birth defects and cardiovascular birth defects.
Both datasets were sorted by SU. The number of live
births was approximated by the number of birth decla-
rations in the at-risk population. Global annual inci-
dences of all birth defects (Iall) and cardiovascular birth
defects (Icv) were estimated at 2.26% and 0.48% of births,
respectively.
Datasets
We generated 20 000 datasets for each baseline risk, i.e.
a total of 40 000 datasets.
Each dataset is entered as a table of 221 rows and 5
columns. The rows contain the coordinates (longitude
and latitude) of a SU, the observed number of cases, the
size of the at-risk population (i.e., the number of live
births) and the expected number of cases in the specified
SU. This last quantity is the product of the global inci-
dence (Iall or Icv) and the at-risk population size in the
SU. The observed case numbers are assumed as inde-
pendent Poisson variables such that
E N ið Þ ¼ μi;N iePois μið Þ; i ¼ 1;…; n
where Ni is the observed number of cases, and μi denotes
the expected number of cases in the ith SU under the null
hypothesis of risk homogeneity.
Figure 1 Representation of the medial axis of the Auvergne
region.
Figure 2 Empirical distribution of WDC size (number of SUs) over 20 000 simulated datasets for two baseline incidences of birth
defects: 2.26% (Iall) and 0.48% (Icv).
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Assessment of type I error
Overall rate
The global type I error rate was estimated by the proportion
of WDC over the 20 000 datasets for each baseline risk.
Spatial distribution
SU participation rate: Participation rate of each WDC in
the overall type I error is equal to 1/m, with m the number
of WDCs. Participation rate of each SU in the overall type I
error was estimated by a weighted sum of the number of
times each SU was included in a WDC. This weight is a
function of m and the length of each WDC (number of SUs
within). For each SU i among the n SUs of the region, the
participation rate Pi in the overall type I error is such that
Pi ¼
Xm
j¼1
Iij mlj
 
−1
where m is the number of WDCs, lj is the length of the
jth WDC and I ij a binary indicator equal to 1 when
the ith SU is within the jth WDC and 0 otherwise. By
construction, Pi ≥ 0 and
Xn
i¼1
Pi ¼ 1, where n is the num-
ber of SUs in the region.
Edge effect: The edge effect is defined here as an in-
homogeneous distribution of Pi characterized by a
gradient from the medial axis (or cut locus or skeleton)
of the region to its edge. This gradient can either be
ascending or descending. The medial axis is the set of
all points having more than one closest point on the
region’s edge [20-23]. The Figure 1 shows the medial
axis of the region under studya. For such a simple poly-
gon, the medial axis is a tree whose leaves are the verti-
ces and whose edges are straight segments reflecting
local symmetries of the shape.
To confirm the presence of an edge effect, we propose
a test whose statistic, referred to as E, is such that
Ε ¼
Xn
i¼1
εi Pi−n
−1
 
εi ¼ 1−
2di
D
 
8>><
>>:
Where di is the minimal Euclidian distance between
the centroid of the ith SU and the edge of the region,
D the maximum Euclidian distance between any point
of the medial axis and the region closest edge, and n the
number of SUs in the region. By construction, as 0 ≥ di ≥
D, -1 ≥ ε i ≥ +1. The coefficient εi is a continuous indi-
cator quantifying how much a point can be considered
“on the edge” of the region. It is referred to as “the edge
Figure 3 SUs participation rates computed over 20 000 simulated datasets for each map. (a) Observed values for baseline incidence of
birth defects set to 2.26% (Iall). (b) Observed values for baseline incidence of birth defects set to 0.48% (Icv).
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coefficient” in the remainder of this paper. For any point
in the region, the closer to the edge, the higher the edge
coefficient, and the closer to the medial axis, the smaller
the edge coefficient. The edge coefficient ranges from -1
for the most “central/medial” points of the region to +1
for points on the edge. For a study region divided into
census tract, each SU is attributed the edge coefficient of
its centroid. All SUs with the same edge coefficient are at
the same distance to the edge and the closer to the medial
axis, the smaller the edge coefficient, tending to -1 for the
most “central” SUs of the region.
The test hypotheses are expressed by
H0 : E ¼ 0
H1 : E≠0

The quantity n-1 is the expected participation rate for
all SUs under the null hypothesis of spatial homo-
geneity in type I error. When Pi is higher than expected
towards the edge of the region, by construction, it is
lower towards the center (as
Xn
i¼1
Pi ¼ 1) and there is an
ascending gradient. On the contrary, when Pi is higher
towards the center of the region, there is a descending
gradient. The statistic E is positive when there is an
ascending gradient of Pi and negative when the gradient is
descending. Indeed, in case of an ascending gradient
 central SUs will tend to have
εi < 0; Pi−n
−1
 
< 0 ð1Þ
 border SUs will tend to have
εi > 0; Pi−n
−1
 
> 0 ð2Þ
and E will tend to be highly positive.
In case of a descending gradient
 central SUs will tend to have
εi < 0; Pi−n
−1
 
> 0 ð3Þ
 border SUs will tend to have
εi > 0; Pi−n
−1
 
< 0 ð4Þ
and E will tend to be highly negative.
Finally, under H0 of spatial homogeneity of type I error,
the sum of all Pi, equal to 1, is homogeneously distributed
among the n SUs with an expected participation rate
Figure 4 Empirical distribution of SUs participation rates computed over 20 000 simulated datasets for two baseline incidences of
birth defects: 2.26% (Iall) and 0.48% (Icv).
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equal to n-1. Under this null hypothesis, the expected value
of (Pi − n
− 1) is null and independent to εi. Consequently,
under null hypothesis, the expected value of E is null.
Since the variance of the E statistic under H0 (spatial
homogeneity of type I error) is unknown, we used
Monte Carlo simulation where the n observed Pi were
randomly distributed 99 999 times among the n SUs in
the region. The p-value was the proportion of elements
among the collection of simulated and observed statistics
which were greater than or equal to the observed value.
The precision of this p-value was thus of 10-5 digits.
Kulldorff’s spatial scan statistic
In this study, we selected Kulldorff ’s spatial scan statistic
[24,25] as a well-known and widely used CDT whose per-
formance has been studied by many authors [1,6,10,26].
The spatial scan statistic detects the most likely cluster
on locally observed statistics of likelihood ratio tests.
The scan statistic considers all possible zones z defined
by two parameters: a center that is successively placed
on the centroid of each SU, and a radius varying
between 0 and a predefined maximum. The true geog-
raphy being delineated by administrative tracts, each
zone z defined by all SUs whose centroids lie within the
circle, is irregularly shaped. Let Nz and nz be respect-
ively the size of the at-risk population and the number
of cases counted in zone z (over the whole region, these
quantities are the total population size N and the total
number of cases n). The probabilities that an at-risk
case lies inside and outside zone z are respectively
defined by pz = nz/Nz and qz = (n-nz)/(N-Nz). Given the
null hypothesis of risk homogeneity H0: pz = qz, versus
the alternative H1: pz > qz and assuming a Poisson
distribution of cases, Kulldorff defined the likelihood
ratio statistics as proportional to
nz
λNz
 nz n−nz
λ N−Nzð Þ
 n−nz
Ι nz > λNz½ ;
Figure 5 Size of the at-risk population for each SU in the Auvergne region, as defined by mean number of live births per year between
1999 and 2006 (source: INSEE). Q1: ≤ 17; Q2: > 17 and≤ 35; Q3: > 35 and≤ 70; Q4: > 70.
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where λ (here equal to Iall or Icv depending on the case
considered) is the global incidence and the indicator
function I equals 1 when the number of observed cases
in zone z exceeds the expected number under H0 of
risk homogeneity, and 0 otherwise. The circle yielding
the highest likelihood ratio is identified as the most
likely cluster. The p-value is obtained by Monte Carlo
inference.
Over the 40 000 simulated datasets, each test was per-
formed with a maximum size of zone z set to 50% of the
total at-risk population, a number of 999 Monte Carlo sam-
ples for significance measures, and an alpha level set to 5%.
Software
Data simulation and analysis were performed on R 2.14.0
[3,27-29], using the function “kulldorff” of the SpatialEpi
package [27] to perform the Kulldorff ’s spatial scan.
Results
Overall rate and WDC characteristics
The overall type I error rate was 5.11% (1021 WDC
over 20 000 datasets; CI 95% [4.80%, 5.42%]) for Iall
and 5.06% (1012 WDC over 20 000 datasets; CI 95%
[4.76%, 5.38%]) for Icv. The average size of WDCs was
21.4 SUs (minimum 1SU, median 11 SUs, maximum
116 SUs) and 23.4 SUs (minimum 1SU, median 11 SUs,
maximum 132 SUs), respectively. The Figure 2 shows
the empirical distribution of the WDC size for each
baseline risk.
SUs participation rates
Figure 3 shows the SUs participation rates for baseline
risks Iall (Figure 3a) and Icv (Figure 3b). The expected
participation rate (n-1) for each SU is equal to 0.452%.
With 0.452% ± 0.147% (mean ± standard deviation) for Iall
and 0.452% ± 0.148% for Icv, the two observed distribu-
tions of participation rates were very close to each other
(Figure 4). The observed values varied from 0.097% to
0.877% for Iall and from 0.091% to 1.03% for Icv.
We sought for a correlation between Pi and size of the
at-risk population (Figure 5) by Spearman’s rank test.
Both coefficients were negative but none resulted in
significant relationship (r = -0.13 with p-value = 0.056 for
Iall and r = -0.11 with p-value = 0.1 for Icv).
Figure 6 Values of the edge coefficient εi computed over a regular sampling of 500 000 points within the region.
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Edge effect
Figure 6 shows the value of the edge coefficient εi com-
puted for a regular sampling of 500 000 points within
the region. Figure 7 shows the value of the edge coeffi-
cient computed for the n = 221 SUs within the region.
With E equal to -0.086 for Iall and -0.074 for Icv, both
simulations resulted in descending gradient of Pi, i.e.
higher Pi for central SUs. As shown by E values, this
gradient was stronger for Iall than for Icv.
As shown in Figure 8, the SUs contributing to the
overall type I error for more than n-1 (Pi > n
-1) were
mostly located away from the border of the region. The
black line delineates a central zone where the edge coef-
ficient is negative and a complementary zone where the
edge coefficient is positive. Within the central zone, red
SUs contribute negatively to E (see Equation 3), on the
contrary, outside the central zone, red SUs contribute
positively to E (see Equation 4).
Both tests were highly significant, with Monte Carlo
p-values both equal to 10-5 (99 999 replicates). Figure 9
shows the simulated null distributions of E and the
observed values for the two simulated baseline risks.
Discussion
We have shown that type I error is heterogeneously dis-
tributed with a descending gradient from center to edge.
Even if global type I error is very near the predefined 5%,
WDCs are rarely located on the edge of the map. In a
survey system, where sensitivity matters over specificity,
it could be argued that since global type I error is pre-
served, the global cost in unfruitful secondary investiga-
tion is not affected by the spatialization of type I error.
Our work did not aim to test for clustering in type I
error rate and thus we did not used CDTs to analyze
the spatial distribution of Pi. We note, however, that
methods such as Bayesian smoothing could be of
interest in the description of the spatial distribution
of type I error. As the presence of an edge effect with
descending gradient was obviously expected, our contri-
bution aimed to describe, quantify and test for this edge
effect. Furthermore, within a given region, the spatial de-
scription of type I error makes possible to see with pre-
cision which detected clusters should be carefully
considered because they are less likely to coincide with
false alarm.
Figure 7 Values of the edge coefficient εi computed for each SU within the region. Each SU is assigned the value of the edge coefficient εi
computed for its centroid.
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Figure 8 Overlaying of the sign of the difference between observed and expected values of SUs participation rates (computed over 20
000 simulated datasets for each map) and the sign of the edge coefficient εi (εi negative in hatched area). (a) Baseline incidence of birth
defects set to 2.26%. (b) Baseline incidence of birth defects set to 0.48%.
Figure 9 Histograms of the null distribution (99 999 replicates) and observed values of E for two baseline incidences of birth defects:
2.26% (Iall) and 0.48% (Icv).
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The edge effect was present and strong, no matter the
baseline risk. Only two levels have been tested for this
risk. One could wonder about a possible correlation
between edge effect and the level of baseline risk. Levels
at regular interval between these two baseline risks are
currently being explored and there is no evidence of
such a correlation so far (data not shown).
The edge effect is indisputable in this study (Figure 8)
and the statistic E has consequently resulted in a highly
significant test. This statistic is based on the edge coefficient
εi that defines what is “on the edge” of the map and what is
not. By using medial axis, we proposed a distance-based
definition, but other parameters could be considered. For
instance, it could be useful to distinguish between two SUs
at the same distance to the edge but in different configura-
tions with one in a “peninsula” (between two edges) and
thus more isolated than the others. To be accounted for,
this factor needs geometrical tools to characterize the
spatial isolation.
Aside from a purely geometrical definition of what is
an edge, confounding factors should also be taken into
account. Suppose that the at-risk population is heteroge-
neously distributed, with more populated areas centrally
localized. Then, suppose again that the at-risk popula-
tion size is negatively correlated to participation rate
(this was not the case in our study). Our test for edge
effect might turn out to be significant, concluding in an
ascending gradient of Pi from center to edge, only due
to this confounding factor. In our simulations, the
at-risk population is effectively more centrally localized.
If the negative correlation between population size and
Pi had been significant, we would have an even stronger
evidence for a descending edge effect regarding Pi from
center to edge, because our results, that turned out to be
significant, would have actually been underestimated.
Even if we did not find any relationship between popu-
lation size and participation rate, other factors (such as
the number of neighbors, the accessibility by road or rail
system, etc.) should be evaluated. The best way to deal
with these confounding factors might be to integrate
them in the construction of ε i for geographical factors
or to replace the constant n-1 by a vector of expected
participation rates for epidemiological factors. For the
E statistic to be equal to 0 under H0 (spatial homogen-
eity of type I error), this last adaptation should be done
in such a way that the sum of all expected participation
rates stays equal to 1.
Our results highlight the edge effect in type I error,
and thus can help the interpretation of real data analysis.
It could be even more useful to provide a way to inte-
grate spatial heterogeneity of type I error in the analysis
itself. Furthermore, adjustment in CDT behavior should
be done to address this issue only if it does not impede
the tests’ power. In a previous simulation study on CDT
performance, we proposed a method to build perform-
ance map based on a systematic spatial evaluation [15].
The now available data for both H1 (single clusters of
4SUs in this previous study) and H0 (risk homogeneity)
in similar settings (same baseline risk and population
size) will enable us to study whether and how it could
be gainful to add a spatial adjustment of type I error.
Conclusion
Spatial heterogeneity of type I error should be consid-
ered when interpreting analysis of real data, because of
the strong edge effect. This work clearly shows that a
detected cluster on the edge of the region of interest
is less common when no alarm should be raised. To
explore all avenues, assessment of edge effect and its
factors, as well as development of tools to integrate it in
routine health survey, should be considered.
Endnotes
aComputation of the straight skeleton was performed
using [30] and the results were imported and displayed with
JTS Topology Suite [31], a software under GNU license.
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